To investigate the abnormal activation of LINC01419 within HCC cells, we utilized MethPrimer (http://www.urogene.org/methprimer) to forecast the presence of CpG islands in the promoter region of LINC01419 (Figure S10C). Here, LINC01419 is linked to hepatocellular carcinoma.